taurine has been researched along with mitozolomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gundersen, S; Pinedo, HM; Renard, J; Smyth, JF | 1 |
| Dexter, TM; Jelinek, J; Kleibl, K; Margison, GP | 1 |
1 trial(s) available for taurine and mitozolomide
| Article | Year |
|---|---|
Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Nitrosourea Compounds; Random Allocation; Taurine | 1989 |
1 other study(ies) available for taurine and mitozolomide
| Article | Year |
|---|---|
Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents.
Topics: Alkyl and Aryl Transferases; Alkylating Agents; Animals; Deoxyribonuclease BamHI; Deoxyribonuclease EcoRI; DNA Restriction Enzymes; Drug Resistance; Escherichia coli; Fluorometry; Hematopoietic Stem Cells; Mechlorethamine; Methyl Methanesulfonate; Methylnitrosourea; Mice; Nitrogen Mustard Compounds; Nitrosourea Compounds; Plasmids; Taurine; Transfection; Transferases | 1988 |